Randomized crossover clinical trial of real and sham peripheral prism glasses for hemianopia
- PMID: 24201760
- PMCID: PMC3945165
- DOI: 10.1001/jamaophthalmol.2013.5636
Randomized crossover clinical trial of real and sham peripheral prism glasses for hemianopia
Abstract
Importance: There is a major lack of randomized controlled clinical trials evaluating the efficacy of prismatic treatments for hemianopia. Evidence for their effectiveness is mostly based on anecdotal case reports and open-label evaluations without a control condition.
Objective: To evaluate the efficacy of real relative to sham peripheral prism glasses for patients with complete homonymous hemianopia.
Design, setting, and participants: Double-masked, randomized crossover trial at 13 study sites, including the Peli laboratory at Schepens Eye Research Institute, 11 vision rehabilitation clinics in the United States, and 1 in the United Kingdom. Patients were 18 years or older with complete homonymous hemianopia for at least 3 months and without visual neglect or significant cognitive decline.
Intervention: Patients were allocated by minimization into 2 groups. One group received real (57-prism diopter) oblique and sham (<5-prism diopter) horizontal prisms; the other received real horizontal and sham oblique, in counterbalanced order. Each crossover period was 4 weeks.
Main outcomes and measures: The primary outcome was the overall difference, across the 2 periods of the crossover, between the proportion of participants who wanted to continue with (said yes to) real prisms and the proportion who said yes to sham prisms. The secondary outcome was the difference in perceived mobility improvement between real and sham prisms.
Results: Of 73 patients randomized, 61 completed the crossover. A significantly higher proportion said yes to real than sham prisms (64% vs 36%; odds ratio, 5.3; 95% CI, 1.8-21.0). Participants who continued wear after 6 months reported greater improvement in mobility with real than sham prisms at crossover end (P = .002); participants who discontinued wear reported no difference.
Conclusions and relevance: Real peripheral prism glasses were more helpful for obstacle avoidance when walking than sham glasses, with no differences between the horizontal and oblique designs. Peripheral prism glasses provide a simple and inexpensive mobility rehabilitation intervention for hemianopia.
Trial registration: clinicaltrials.gov Identifier: NCT00494676.
Figures





Similar articles
-
A pilot randomized controlled trial comparing effectiveness of prism glasses, visual search training and standard care in hemianopia.Acta Neurol Scand. 2017 Oct;136(4):310-321. doi: 10.1111/ane.12725. Epub 2016 Dec 27. Acta Neurol Scand. 2017. PMID: 28028819 Clinical Trial.
-
Community-based trial of a peripheral prism visual field expansion device for hemianopia.Arch Ophthalmol. 2008 May;126(5):657-64. doi: 10.1001/archopht.126.5.657. Arch Ophthalmol. 2008. PMID: 18474776 Free PMC article. Clinical Trial.
-
Clinical and laboratory evaluation of peripheral prism glasses for hemianopia.Optom Vis Sci. 2009 May;86(5):492-502. doi: 10.1097/OPX.0b013e31819f9e4d. Optom Vis Sci. 2009. PMID: 19357552 Free PMC article.
-
Homonymous hemianopia and related visual defects: Restoration of vision after a stroke.Acta Neurobiol Exp (Wars). 2013;73(2):237-49. doi: 10.55782/ane-2013-1933. Acta Neurobiol Exp (Wars). 2013. PMID: 23823985 Review.
-
Homonymous Hemianopia and Vision Restoration Therapy.Neurol Clin. 2017 Feb;35(1):29-43. doi: 10.1016/j.ncl.2016.08.010. Neurol Clin. 2017. PMID: 27886894 Review.
Cited by
-
The effect of visual rivalry in peripheral head-mounted displays on mobility.Sci Rep. 2023 Nov 18;13(1):20199. doi: 10.1038/s41598-023-47427-8. Sci Rep. 2023. PMID: 37980436 Free PMC article.
-
Peripheral Prisms Improve Obstacle Detection during Simulated Walking for Patients with Left Hemispatial Neglect and Hemianopia.Optom Vis Sci. 2018 Sep;95(9):795-804. doi: 10.1097/OPX.0000000000001280. Optom Vis Sci. 2018. PMID: 30169355 Free PMC article.
-
Considering Apical Scotomas, Confusion, and Diplopia When Prescribing Prisms for Homonymous Hemianopia.Transl Vis Sci Technol. 2013 May;2(4):2. doi: 10.1167/tvst.2.4.2. Epub 2013 May 29. Transl Vis Sci Technol. 2013. PMID: 24049719 Free PMC article.
-
Head-Mounted Display Technology for Low-Vision Rehabilitation and Vision Enhancement.Am J Ophthalmol. 2017 Apr;176:26-32. doi: 10.1016/j.ajo.2016.12.021. Epub 2016 Dec 31. Am J Ophthalmol. 2017. PMID: 28048975 Free PMC article. Review.
-
Gaze Scanning at Street Crossings by Pedestrians With Homonymous Hemianopia With and Without Hemispatial Neglect.Invest Ophthalmol Vis Sci. 2023 Nov 1;64(14):26. doi: 10.1167/iovs.64.14.26. Invest Ophthalmol Vis Sci. 2023. PMID: 37975848 Free PMC article.
References
-
- Young CA. Homonymous hemianopsia during pregnancy aided by reflecting prism. Arch Ophthalmol. 1929;2:560–565.
-
- Smith JL, Weiner IG, Lucero AJ. Hemianopic Fresnel prisms. J Clin Neuroophthalmol. 1982;2:19–22. - PubMed
-
- Woo GC, Mandelman T. Fresnel prism therapy for right hemianopia. Am J Optom Physiol Opt. 1983;60:739–743. - PubMed
-
- Perez AM, Jose RT. The use of Fresnel and ophthalmic prisms with persons with hemianopic visual field loss. J Vis Impair Blind. 2003;97:173–176.
-
- Hedges TR, Jr., Stunkard J, Twer A. Fresnel prisms--their value in the rehabilitation of homonymous hemianopsias. Klin Monbl Augenheilkd. 1988;192:568–571. - PubMed
Publication types
MeSH terms
Substances
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical